US Patent 11396545 BTLA agonist antibodies and uses thereof
Patent 11396545 was granted and assigned to Eli Lilly and Company on July, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 17, 2020
0
Date of Patent
July 26, 2022
0
Patent Applicant
Patent Application Number
16792396
0
Patent Inventor Names
Andrew Charles Vendel
0
Shane Krummen Atwell
0
Victor H. Obungu
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11396545 BTLA agonist antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.